No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Impact of COVID-19 on supply chains
China is highly integrated within the global economy and has impressive transportation networks, which means that supply chain disruptions go far beyond regional concerns.
Employee safety and supply chain impact primary business concerns related to COVID-19 outbreak: Survey
The COVID-19 pandemic has presented operational and financial challenges for organisations and businesses across the world.
Drug supply chain disruptions due to COVID-19 a very high concern: Poll
Analysis of a poll conducted by Verdict to assess the impact of COVID-19 on the drug supply chain showed that...
Covid-19 pandemic: knock-on effects for pharma supply chains
Covid-19 originated in China, which is where the clear majority of APIs for drugs are manufactured; China’s lockdown had a knock-on effect on its neighbour India, which relies on those APIs to produce generic drugs. What long-term impact could this have on supply chains and could it push pharma companies to seek to move their API manufacturing back to home soil?
Life Sciences Supply Chain: Covid-19 triple threat
By Bill DuBois, Director Industry, Kinaxis. You can’t help but notice the significant run on products as people stockpiled in...
Pharmaceutical professionals say employee safety and supply chain disruption are top Covid-19 concerns
Pharmaceutical industry professionals around the world believe that employee safety and supply chain disruption are their businesses’ top concerns from...
Four Steps on How to Prepare Your Post-Covid-19 Clinical Trial
Clinical trials around the world are being disrupted by the Covid-19 pandemic, leaving sponsors with no choice sometimes but to...
Covid-19-induced digital transformation did prioritise blockchain
Blockchain has been long touted as a technology that can improve nearly every component of the pharmaceutical value chain, from increasing supply chain transparency to enhancing data collection in clinical trials.
Pharma FDI in the times of Covid-19: A challenging pill to swallow
With supply chains disrupted and the world veering all its attention towards halting Covid-19, FDI flows into the pharmaceutical sector...
Ending patent monopolies can save lives – leading macroeconomic influencers
Monopoly patents have made vaccine prices far more expensive than in a free market, limiting the availability of vaccines and research to control the pandemic.
How supply chains became headline news
A strange thing has happened over the past two Covid-affected years. On top of the tragic death toll and lives...
ESG Top Trends: Healthcare ESG Impact
All aspects of environmental, social, and governance (ESG) are important, and in the healthcare industry, companies must excel across all...
Companies in APAC region predict COVID-19 pandemic to impact revenue: Survey
The measures taken to control the spread of the COVID-19 pandemic has impacted industries in regions across the world differently. While Asia was initially affected, the impact soon spread to Europe, North America and other regions and continues despite widespread measures.
Governments can avoid potential cancer drug shortages amid Covid-19 pandemic
As the Covid-19 pandemic escalates, the spread of the infection is putting increasing pressure on healthcare systems worldwide. While valuable...
Covid-19: emerging findings and implications in cardiovascular and metabolic disorders
The Covid-19 pandemic raging across the globe has a multitude of implications across healthcare sectors and disease indications. The cardiovascular...
Pharma FDI in the times of Covid-19: A challenging pill to swallow
[caption id="attachment_253" align="alignnone" width="1000"] Credit: Shutterstock[/caption] With supply chains disrupted and the world veering all its attention towards halting Covid-19,...
LLamasoft Q&A: drug stockpiles and the need for advanced scenario planning
The Covid-19 pandemic has seriously depleted the UK’s Brexit drug stockpiles. LLamasoft’s Matthew Woodcock explains how contingency planning and the building of resilience can prevent such significant disruption to supply chains and stockpiles in the future.
Covid-19 forces a rethink of global supply chains
As companies across the world are forced to examine the cracks in their supply chains in the wake of the...
Calibrating cold chain systems for cell and gene therapies in a post-pandemic world
Pharmaceutical supply chain partners are trying to create an efficient cold chain system to transport cell and gene therapies.
API chemical, commercial packaging, and logistics and transportation some the biggest commercial supply chain concerns amid COVID-19, reveals survey
The impact of the COVID-19 pandemic has forced pharmaceutical companies to revaluate their supply chains including reshoring manufacturing of APIs, intermediates and other products.